
EMMA AARNIO
Senior Researcher
Contact info
Organization
Faculty of Health Sciences, School of Pharmacy
emma.aarnio@uef.fi
Phone
-
Keywords
Research groups - UEF
-
Pharmaceutical Policy Research Group
-
Pharmacoeconomics & Outcomes Research Group
-
Center for Social and Health Care Effectiveness -project
-
House of Effectiveness
Links
Publications
-
Härkönen, Ulla; Rannanheimo, Piia; Leppänen, Laura; Aarnio, Emma. 2021. Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa Sic! 3/2021: 5 s,. 2021
-
Jalkanen, Kari; Järvenpää, Riia; Tilles-Tirkkonen, Tanja; Martikainen, Janne; Aarnio, Emma; Männikkö, Reija; Rantala, Eeva; Karhunen, Leila; Kolehmainen, Marjukka; Harjumaa, Marja; Poutanen, Kaisa; Ermes, Miikka; Absetz, Pilvikki; Schwab, Ursula; Lakka, Timo; Pihlajamäki, Jussi; Lindström, Jaana; The StopDia Study Group. 2021. Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study JMIR diabetes 6 3: e21356. 2021
-
Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia. 2021. Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla Lääkärilehti 76 1-2: 48-52. 2021
-
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease Frontiers in pharmacology 12: 687549. 2021
-
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease Biomedicines 9 9: 1280. 2021
-
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma. 2021. Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease Biomedicines 9 12: 1800. 2021
-
Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne. 2021. Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis Bmc health services research 21 1: 916. 2021
-
Aarnio, Emma; Huupponen, Risto; Martikainen, Jaana E; Korhonen, Maarit J. 2020. First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research Research in social and administrative pharmacy 16 4: 553-559. 2020
-
Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne. 2020. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes Bmc health services research 20: 1095. 2020
-
Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne. 2020. Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes Health policy 124 12: 1310-1316. 2020